Fragment-screening platform for finding inhibitors of oxidative stress and inflammation

The aim is to make an efficient platform for screening so-called fragments that are used as starting points for making drug-like small molecules against disease-relevant proteins. We will acquire a state-of-the-art surface plasmon resonance (SPR) machine and collect two new fragment libraries. This can lead to new tool compounds for research and drug leads and support many other projects.